Sitemap

Pages

• Calendar
• Contact
• Global map
• Home
• News
  • Events
  • Firm Annoucements
  • In the News
  • Media Contacts
  • Media Kit
• People
  • Attorneys
• Privacy
• Profile
  • Careers
  • Community Involvement
  • Overview
  • Values
• Sitemap
• Thank You
• Thanks
• Yates

Posts by category

• Category: Allan Joseph
  • VIDEO: Allan Joseph and Family Central Featured on BECON TV
  • 3 Ways FRCP Amendments Could Affect Companies
  • Miami: The City of Fun, Sun and International Arbitration
  • Jury Is Still Out On Scope Of Arbitration Clauses
  • Law 360: Jury Is Still Out On Scope Of Arbitration Clauses
  • U.S. Tax Court Rules Silent Illinois Politician Committed Tax Fraud; Statute of Limitations does not Bar Assessment of Old Deficiency
• Category: Andrew Ittleman
  • He Knew All About Money Launderers. The U.S. Says He Joined Them
  • Disclosure requirements for all-cash purchases have been eased — slightly
  • Regulator renews order targeting shell companies buying South Florida real estate
  • The new policy will increase scrutiny and pressure on stem cell clinics, according to industry experts.
  • Money Laundering: US crackdown on Venezuelan cash
  • Google is banning ads for quack cures after years of profiting from them
  • New Google policy bars ads for unproven stem cell therapies
  • Can Facebook Really Launch Libra in 2020? The Devil Will Be in the Details
  • Key Takeaways From the Insys Prosecution
  • Judge Says FDA Can Stop Clinic from Selling Stem Cell Treatments
  • Approval of Epidiolex, a Cannabis derived drug for the treatment of Seizures
  • FDA Says ‘Rhino’ Male Sexual Enhancement Products May Pose Health Dangers
  • Government bans on pot research have created room for marijuana health hype
  • This cannabis-derived drug just got approved, but that won’t make it easier to get edibles
  • Feds Look to Seize Porsche Tower Condo Unit Tied to $1B Money Laundering Case
  • Russia Sanctions Bill Also Targets Real Estate Deals
  • When the fat stem cells hit the fire, will clinics sued by FDA opt to stop soon?
  • Las razones para desconfiar de los tratamientos milagrosos con células madre
  • How to Answer Tough Law School Interview Questions
  • What’s the Best Bitcoin Wallet?
  • Blockchain Technology May Change the World, But What Are the Risks?
  • Bitcoin vs. the U.S. Dollar: Which Is the Real Bubble?
  • Bitcoin is Booming in Miami. But can you buy a House with it?
  • What’s the Best Bitcoin Wallet?
  • Why the Trump Organization Can Play Dumb on Money Laundering
  • FinTech Seeing Usage Surge, but Some Banks Still Fighting it
  • Feds Widen Hunt for Dirty Money in Miami Real Estate
  • FinCEN Issues Revised Order Targeting Shell Companies Buying Real Estate
  • Australian Money-Laundering Alliance a Stretch for U.S.
  • Marijuana Stocks: How to Invest in Marijuana Today
  • Program to Track Laundered Money in Luxury Real Estate Continues
  • Feds renew crackdown on dirty money in Miami real estate
  • U.S. Renews Real-Estate Data Targeting Order
  • Federal regulator renews real estate money laundering dragnet in South Florida
  • States Keep Passing Laws On Marijuana As Anti-Marijuana Leaders Take Over
  • Will Trump end crackdown on dirty cash in luxury real estate?
  • Paul Vigna & Michael Casey, “The Age of Cryptocurrency: How Bitcoin and Digital Money Are Challenging the Global Economic Order,” 258-59 (2015)
  • The Money Services Banking Crisis: A Complex Solution for a Simple Problem
  • What’s Worse Than Pot Staying Illegal? Pot as an FDA-Regulated Drug
  • How secret offshore money helps fuel Miami’s luxury real-estate boom
  • Coral Gables’ Gibraltar Private Bank fined $4 million for Rothstein-related issues
  • Gibraltar hit with regulatory action for secrecy act and anti-money laundering violations
  • No More Anonymity for Cash Buyers of Luxury Miami-Dade Homes
  • Real-Estate Faces New Compliance After Getting A Pass
  • How the Feds Blew a Case Against an Alleged South American Drug Money Launderer
  • Here’s Why Feds Are Targeting Cash Buyers in Miami-Dade Luxury Home Sales
  • MONEY LAUNDERING: Feds moves to strip secrecy from cash real estate deals in Miami
  • FinCEN Continues Patriot Act Expansion Amid Real-Estate Order
  • Chicago Improves Opioid Case With Details About Doctors
  • Banking on Weed a Risky Business
  • FinCEN Targets Check-Cashers in South Florida
  • FinCEN Order Targets Tax Refund Check Fraud In South Fla.
  • Regulators issue dragnet in Miami-Dade, Broward to root out tax refund fraud
  • Feds target tax-refund ripoff with new order
  • The Potentials and Pitfalls of Marijuana Investments
  • What a FinCEN dragnet means for 700 Miami businesses
  • Pot, Bitcoin Companies Pay Steep Fees for Bank Access
  • Industry: BitLicense Revision Leaves Room for Continued Debate
  • Podcast: Criminal defense attorney Andrew Ittleman on digital currency law
  • Federal Marijuana Regulation: Why is Flexibility Critical in the Dawn of Legalization?
  • Podcast: Taxing Miners (but not like Forty-Niners) with Andrew Ittleman
  • #BTCMiami: Regulation Panel Predicts New State Law Imminent — and “Look Out for the Lawsuits”
  • Andrew Ittleman will speak on the topic Banking Marijuana
  • BigLaw Stands To Gain From New US Policy In Cuba
  • Western Union BitLicense Response is Pro-Bitcoin, Legal Experts Say
  • FinCEN Rules Bitcoin Payment Processors, Exchanges are Money Transmitters
  • Governor Scott Signs Medical Marijuana Bill
  • Bitcoin seeps into mainstream
  • Lawyers Navigate Rising Financial Crime Risks amid Debate Over Regulation for Gatekeepers’
  • Andrew Ittleman: Hurdles in Accessing Banking Services
  • How Can FDA More Reasonably Regulate Autologous Stem Cell Procedures?
  • Is it drug manufacturing or the practice of medicine? Stem cell therapy debate just getting started
  • Eleventh Circuit Court of Appeals Creates Deeper Circuit Split Over Pre-Trial Restraint of Assets
  • Feds Winning Battle against Health Care Fraud
  • Mistrial Declared in Foreign Corrupt Practices Act Case After Jury Could Not Reach Verdict
  • Andrew Ittleman of Fuerst Ittleman to Instruct at 2011 US Money Transmitter Seminar in Los Angeles
  • Judge Agrees Agency for Health Care Administration Rule Goes Beyond Regulatory Powers
  • Hunton & Williams delays record disclosures in Stanford case
  • Mitchell S. Fuerst, Esq., and Andrew S. Ittleman, Esq., C.A.M.S. will speak at the International Money Transmitters Convention
• Category: Blog
  • Florida Ad Valorem Taxation Update: First District Court of Appeal Broadly Interprets Charitable Use Exemption to Ad Valorem Taxation
  • “Dear Florida Supreme Court”: Are Zero-Liability Exculpatory Clauses Enforceable?
  • Florida Supreme Court reverses course: the Daubert Standard is the law of the land
  • Administrative Law Update: Calls for End to Chevron Deference
  • Federal Litigation Update: Amendments to the Local Rules for the Southern District of Florida Go Into Effect December 1, 2017
  • OFAC Compliance Update: OFAC Settlement with Cartier Highlights Need for Robust Due Diligence by Retailers to Ensure Compliance With OFAC Regulations
  • IRS and FinCEN Offer Relief to Victims of Hurricane Irma
  • Marijuana Regulatory Compliance Update: Banking and Casino Industries Call For Additional Marijuana-Related Business Guidance From U.S. Treasury
  • 4 Key Defenses to FBAR Liability
  • Federal Litigation Update: Amendments to the Local Rules for the Southern District of Florida Go Into Effect December 1, 2016
  • MSB Regulatory Update: Workers’ Compensation Fraud in Florida and its Continuing Effect on Check Cashers
  • Asset Forfeiture Update
  • Marijuana Regulatory Update: FDA Issues Warning Letters to CBD Dietary Supplement Companies
  • Anti-Money Laundering Compliance Update: FinCEN announces new reporting requirements for all-cash real estate transactions in Miami and New York City
  • Marijuana Banking Compliance Update: U.S. District Court for Colorado Dismisses Suit by Colorado Credit Union against Federal Reserve; Reveals Gap between Federal “Guidance” and Federal “Law”
  • DOJ Begins Criminal Investigation of Blue Bell Food Safety Violations
  • FDA Announces 2016 Public Hearing on Draft HCT/P Guidance Documents
  • Civil Litigation Update: Federal Rules of Civil Procedure Substantially Amended.
  • Challenging the arbitrability of arbitration provisions
  • Yates Memo: FDA and DOJ to Continue Pursuing Civil and Criminal Penalties Against Individuals Engaged in Corporate Misconduct
  • Florida Healthcare Litigation Update: Health Care Referral Sources Constitute a “Legitimate Business Interest” Entitled to Protection in Non-Compete Agreements…At Least, For Now.
  • The Yates Memo: United States Department of Justice Requires Individual Accountability for Corporate Wrongdoing
  • Tenth Circuit affirms dismissal of marijuana-related business’s bankruptcy petition
  • Florida Litigation Update: Certified Conflict Regarding Enforcement of Restrictive Covenants in Employment Agreements
  • Food Safety in the News: FDA Creates an Accelerated Path for Food Importers
  • OFAC Publishes New Venezuelan Sanctions Regulations
  • Appellate Litigation Update: Eleventh Circuit Overturns Precedent, Permits Supplemental Briefing on Issues Not Initially Raised in Briefs
  • FTC Litigation Update: FTC v. Bayer Litigation: What Type of Evidence Is Needed to Substantiate Probiotic Claims?
  • Complex Litigation Update: Eleventh Circuit Targets “Shotgun Pleadings,” Clarifies Definition
  • Criminal Tax Litigation Update: Seventh Circuit Affirms District Court’s Sentence of Probation for Beanie Babies Creator
  • Third Circuit Clarifies Mental State Required for Hobbs Act Extortion Conviction
  • United States Court of Appeals for the First Circuit: United States Bankruptcy Code Preempts Puerto Rico from Providing Municipalities with Statutory Bankruptcy Relief
  • Tax Litigation Update: DC Circuit Rejects IRS’s Broad Interpretation of Anti-Injunction Act
  • Tax Litigation Update: D.C. Circuit Holds Tax Court Required to Articulate Basis for Dismissal Based on Lack of Jurisdiction
  • The Supreme Court of the United States: Law Enforcement Must Afford Hotel Owners Precompliance Review before Performing a Warrantless Search Pursuant to a Municipal Code
  • Criminal Law Update: Supreme Court Rules that Child’s Statements to Teacher do not Implicate the Sixth Amendment’s Confrontation Clause
  • Natural Products Litigation Update: The FDCA May Not Explicitly Preempt a Judicial Interpretation of the Term “Natural”
  • Increasing Regulation for U.S. Foreign Investors
  • FTC Advertising Law Update: FTC Issues Updated FAQs to Endorsement Guides
  • White Collar Criminal Defense Update: Second Circuit Emphasizes Constitutional Right to Impartial Jury, Upholds High Standard to Prove Waiver
  • Tax Litigation Update: Ninth Circuit Enforces Two-Prong Test to Determine Transferee Tax Liability
  • Marijuana Regulatory Update: FDA Concludes CBD Products Are Not Dietary Supplements
  • Complex Litigation Update: Ninth Circuit Holds Magistrate Judges Powerless to Order Remand
  • Hastert Indictment: How the Bank Secrecy Act Can Criminalize Otherwise Lawful Activity
  • Eleventh Circuit Reverses District Court’s Collateral Estoppel Ruling, Giving A Dietary Supplement Company Another Chance To Substantiate Advertisements.
  • Florida Commercial Litigation Update: Cross-Border Contracts and Forum Selection Clauses
  • Complex Litigation Update: Eleventh Circuit Holds Engle-progeny State-law Claims Preempted by Federal Law
  • Florida Litigation Update: Voluntarily Dismissal Trumps Arbitration Award
  • Trade Based Money Laundering in the News: Miami-Area Electronics Exporters Targeted in FinCEN Anti-Money Laundering Initiative
  • Class Action Litigation Update: Who Should Decide Whether an Arbitration Clause Permits Classwide Arbitration: the Court or the Arbitrator?
  • Complex Commercial Litigation Update: New York’s Separate Entity Rule and the Reemergence of Florida as a Potential Gateway for Judgment Creditors to Seize Debtors’ Foreign Assets in Enforcement and Collection Proceedings
  • Complex Litigation Update: Bridging the Gap between Data on Causation of Lost Profits and the Admissibility of Expert Opinions
  • New York Clarifies Position On Licensing Of Internet Based Money Transmitters
  • Same Surgical Procedure Exception under 21 CFR 1271.15(b): FDA Raises More Questions Than it Answers Regarding the Scope of the Exception
  • Money Laundering in the News: Los Angeles Fashion District Raid Puts Trade-Based Money Laundering and Black Market Peso Exchange in Spotlight
  • Florida Litigation Update: Appeals Court Clarifies Procedure to Execute Against Alcoholic Beverage License
  • Tax Litigation Update: Ninth Circuit Decision Provides Significant Support for Taxpayers Seeking to Discharge Tax Debt in Bankruptcy
  • Third Circuit decision highlights power of “good faith exception” to the exclusionary rule
  • Bitcoin Regulatory Update: CFPB Issues Consumer Advisory Regarding Virtual Currencies, Begins Accepting Complaints
  • International Tax Compliance Update: Renouncing U.S. Citizenship to Avoid Taxes: Is It Worth It?
  • Florida Appeals Court Clarifies Law On Derivative And Direct Shareholder Lawsuits
  • United States Supreme Court: Warrants are required to search digital data on seized cell phones
  • Tax Litigation Update: Eleventh Circuit Holds Clear and Convincing Evidence Standard Applies to Penalties Imposed under IRC § 6701
  • International Tax Compliance Update: Offshore Voluntary Disclosure Program Modifications: A Trap for the Unwary
  • Food Labeling and Marketing after POM LLC v. Coca-Cola Co.: Why Compliance with FDA Regulations May Not Be Enough
  • U.S. District Court rules that FTC can regulate payday lenders regardless of American Indian Tribal affiliation, finds lender violated FTCA.
  • International Tax Compliance Update: IRS Hints at Coming Changes for Certain OVDP Filers
  • FDA Regulatory Update: International Crack Down on Online Pharmacies Identifies Over 1,900 Websites Selling Unapproved or Potentially Counterfeit Drugs to U.S. Consumers
  • FDA Publishes New Draft Guidance on Biosimilars As Congress Raises Questions About FDA’s Use of Draft Guidance Documents
  • “Prescription” v. “Recommendation”: How State Medical Marijuana Laws May Insulate Treating Physicians From Liability Under The Controlled Substances Act
  • FATCA Update: As Additional Countries Agree to Share International Tax Information, Hiding Assets Abroad becomes Increasingly Difficult
  • Florida Litigation Update: Arbitration Clauses are Not Always Enforceable
  • Tax Litigation Update: United States v. Clarke Tests Limits of IRS Summons Enforcement Power
  • White Collar Criminal Defense Update: Third Circuit Court of Appeals Discusses “Willful Blindness” Jury Instruction and Burden Shifting
  • False Claims Act Litigation Update: Bayer Decision Sheds Light on Pleading in False Claims Act Cases
  • Florida Supreme Court Holds Statutory Cap on Non-Economic Wrongful Death Damages in Medical Malpractice Actions Violates the Equal Protection Clause of the Florida Constitution
  • Your Expectation of Privacy in Your Cell Phone is Currently Governed by the Law of the State in Which You are Arrested
  • Complex Litigation Update: SCOTUS Allows Plaintiffs’ State-Law Class Actions Against Law Firms, Financial Firms, and Others to Proceed
  • Marijuana Taxation Update: State Sanctioned Marijuana Industry Must Keep the Federal Anti-Drug Trafficking Tax Code in Mind
  • Florida Business Litigation Update: Confidential Settlements Really Need to Remain Confidential
  • Tax Litigation Update: Eleventh Circuit Reverses Tax Court in Virgin Islands EDP Residency Cases
  • Florida Criminal Law Update: Florida Appeals Court Declares Strict Liability Statute Unconstitutional
  • CMS Expands Moratorium On New Home Health Agencies To Broward County; Extends Moratorium In Miami-Dade and Monroe Counties
  • Florida Business Litigation Update: Prevailing Party Attorneys’ Fees
  • Criminal Tax Litigation Update: Courts are Consistently Ruling that the Act of Production Privilege Will Not Defeat Grand Jury Subpoenas Calling for Foreign Bank Account Statements
  • Tax Litigation Update: Second Circuit Tweaks its Standard of Review in Tax Cases Involving Mixed Questions of Law and Fact; Decides Complex Tax Controversy Involving “Midco” Transaction
  • Tax Litigation Update: The D.C. Circuit is the Proper Venue for Many Appeals of Tax Court Cases
  • Tax Litigation Update: Determination Of Proper Appellate Court For Review Of Certain Tax Court Cases In Flux
  • Raminfard Guilty Plea Highlights Complexity Of International Tax Compliance, Seriousness Of Violations, Importance Of Irs Offshore Voluntary Disclosure Program
  • Florida Business Litigation Update: The Carmack Amendment Preempts Virtually Everything
  • Litigation Update – The Electronic Loss of Privilege
  • False Claims Act Litigation Update: Florida Federal Court Finds Hospital Violated Stark Law Via Oncologist Bonus Compensation System
  • IRS Makes Significant Changes to Innocent Spouse Relief
  • Criminal FBAR Prosecutions Underscore Importance of IRS Offshore Voluntary Disclosure Program
  • FDA Regulatory Update: FDA to Recommend Reclassifying Hydrocodone Combination Drugs; Issue Highlights Cooperative Relationship Between FDA, DEA
  • International Tax Compliance Update: IRS to Issue ”John Doe” Summonses Seeking Information Regarding U.S. Taxpayers with Undisclosed Offshore Bank Accounts
  • TAX REFUND LITIGATION UPDATE: Court of Federal Claims Relies on “Substance Over Form” Doctrine to Recharaterize Transaction
  • Litigation Update: Appellate Arbitration
  • Litigation Update: American Arbitration Association Announces Changes to Commercial Arbitration Rules
  • Third Circuit Decision Requires Warrant for GPS Monitoring and Limits Good-Faith Exception to the Exclusionary Rule
  • FDA Medical Device Regulation Update: FDA Issues Final Rule for Unique Device Identification System
  • IRS Requiring Taxpayers to File FBARs Electronically Raises Concerns About Delinquent Filing and Offshore Voluntary Disclosure Program
  • Tax Practictioners Report Increase in Summons Issuance; IRS Issues New Guidance on Informal Document Requests
  • U.S. Department of Justice & Swiss Federal Department of Finance Enter into Historic Agreement Regarding Tax Evasion Investigations
  • FDA Regulatory Update: What Does “Natural” Mean? Courts Divided on Whether to Seek FDA’s Input
  • Litigation Outlook: Sender Beware: Texting a Driver May Impose Liability on the Sender
  • Healthcare Regulation Update: GAO Makes Recommendations to HHS and CMS Regarding Medicare Audit Consistency
  • House Bill Proposes Narrowing Scope Of Firpta; Eases Burdens On Reits
  • FATCA Update: IRS Introduces FATCA Registration Portal While Foreign Financial Institutions and U.S. Expatriates Push Back
  • Tax Litigation Update: Second Circuit Decision Limits Deductibility of Life Insurance Dividends
  • Healthcare Regulation Update: CMS to Develop New Integrity Contractors Called “Unified Program Integrity Contractors”
  • Florida Corporate and Business Law Update: The Florida Revised Limited Liability Company Act, Chapter 605 of the Florida Statutes, Modernizing Florida’s Limited Liability Company Laws
  • Business Litigation Update: When Settlement Agreements Settle Nothing
  • Healthcare Regulation Update: Centers for Medicare and Medicaid Services Announces Enrollment Moratorium On New Home Health Agencies in Miami-Dade and Monroe Counties
  • FTC Regulatory Update: FTC Settles with Marketers of Bed Bug and Head Lice Treatments; Highlights Confusing Interplay Between FTC and FDA
  • FATCA Compliance Update: U.S. Treasury Announces Six Month Delay In Implementing FATCA
  • Food Safety Regulatory Update: Court Imposes Deadlines on FDA to Promulgate and Implement FSMA Rules by 2015
  • FDA Tobacco Regulation Update: FDA announces first substantial equivalence decisions for tobacco products
  • Compound Pharmacy Regulatory Update: Senate to Vote on Proposed Legislation Granting FDA Broad Authority to Regulate Compounding Pharmacies
  • FDA Regulatory Update: FDA Commissioner Suggests that New LDT Regulations are Forthcoming; Laboratory Industry Challenges FDA’s Authority to Regulate LDTs
  • FDA Regulatory Update: Laboratory-Developed Tests Once Again Come Under FDA’s Microscope and Laboratory Industry Opposes
  • Tax Litigation Update: IRS Commits to Prevent Double Taxation in Virgin Islands Economic Development Program Case
  • Virgin Islands Economic Development Program Update: Tax Court: Statute of Limitations Triggered by Filing Tax Return with Virgin Islands Bureau of Internal Revenue
  • Florida Business Litigation Update: Florida Appeals Court Requires Insurer to Provide Separate Counsel for Multiple Insureds Under Single Policy
  • International Tax Compliance Update: Florida Couple Indicted for Failing to Report Offshore Bank Accounts as IRS Continues Enforcement Against Offshore Tax Evasion and FBAR Violations
  • Update: FDA Regulation of Marijuana “Medibles” Presents Challenges and Uncertainty for Marijuana-based Food Manufacturers and Distributors
  • Florida Complex Litigation Update: Raymond James Financial Services, Inc. v. Phillips: Florida Supreme Court rules that statute of limitations applies to arbitration
  • Energy Drink Regulatory Update: Monster Sues City of San Francisco in Federal Court, City Fires Back in California State Court
  • Update: Banking Difficulties May Lead Marijuana Dispensaries to Commit Bank Fraud
  • Tax Compliance Update: IRS Aggressively Pursues Foreign Banks; Offshore Voluntary Disclosure Programto Remain Open Indefinitely
  • Medical Device Update: FDA Regulation of Tanning Beds, “Henceforth to be Known as Sunlamp Products”
  • FDA Shines a Light on Tanning Bed Safety, Proposes Device Reclassification and Warnings to Users Under 18
  • IRS Issues “John Doe Summons” to Wells Fargo Seeking Identities of U.S. Taxpayers with Offshore Accounts at First Caribbean International Bank
  • A Wake-Up Call to the Food Industry: FDA Announces Investigation into Use of Caffeine in Food
  • Online Sales Taxes Emerging as New York Court of Appeals Shoots Down Overstock and Amazon’s Constitutional Objections
  • FDA Issues Two Warning Letters for Social Media Use: FDA Does Not Approve of “Liking” Consumer Claims and Targets Website Search Results
  • Third Circuit Court of Appeals Issues Landmark Decision in Virgin Islands Economic Development Program Case
  • Capital Records v. ReDigi, Inc.: New York District Court Determines that First Sale Doctrine does NOT apply to Digital Media. Did They Get it Right?
  • Federal Court Orders FDA to Approve OTC Sales of “Morning-After Pill,” Finds Current Age and Point-of-Sale Restrictions to be Arbitrary and Capricious
  • CMS To Post Additional Nursing Home Deficiency Data Online
  • FDA Energy Drink Regulation in the News: Health Experts Push for Regulatory Changes and Monster Moves to Market as a Beverage Instead of as a Dietary Supplement
  • Real Estate Litigation Update: Statute of Frauds? It Had Better Be Written. Sort of.
  • A Supreme Court Win for U.S. Consumers
  • POM Appeals FTC Final Order Regarding Deceptive Claims
  • Business Litigation Update: Suddenly, Contracting Parties Face Tort Risks in Florida
  • The Latest Zpic Target: Medicare Cost Reports
  • US Court Orders Wegelin to Pay a Total Penalty of $74 Million
  • Third Circuit Court of Appeals Affirms Tax Court Decision on CARDS Tax Shelter
  • Ernst & Young to Pay $123 Million to Resolve Federal Tax Shelter Fraud Investigation
  • Business Litigation Update: The Economic Loss Rule Exiled to its Humble Beginnings
  • Update: IRS Continues To Use Anti-Drug Trafficking Tax Code Provision To Limit The Ability Of Marijuana Dispensaries to Deduct Business Expenses
  • Customs Sharing Hard Times with Importers and Travelers
  • IRS Issues Guidance for Native Americans Regarding Tribal Trust Settlements
  • Eleventh Circuit Court of Appeals Sustains Required Records Exception to the Fifth Amendment
  • 11th Circuit Case Signals Split on Law vs. Regulation vs. … Contract?
  • Miami: Our Best Climate is the One Serving Your Business
  • CBP Inspects Almost a Billion Ways to Say “I Love You”
  • Florida Litigation Update: Does the Court Have the Authority to Sanction a Party After Voluntary Dismissal is Filed
  • How to Ensure That Your Company’s Data Doesn’t Get Lost in the Clouds PART III
  • Recent Conviction of Medical Marijuana Distributor Highlights Continuing Federal Efforts To Prosecute Medicinal Marijuana Under The CSA
  • Construction Litigation Update: Florida Supreme Court Rules that Unlicensed Contractors Cannot Enforce Construction Contracts
  • How to Ensure That Your Company’s Data Doesn’t Get Lost in the Clouds: Part II
  • FTC Commission Upholds POM Wonderful Decision Regarding Deceptive Claims
  • Eleventh Circuit Upholds Florida’s “Patient Self-Referral Act of 1992” as Constitutional
  • Diamond Aircraft Piloting a Change in Floridas Attorneys Fees Law
  • How to Ensure That Your Company’s Data Doesn’t Get Lost in the Clouds
  • Uncertainty Regarding the Future Regulation of Compounding Pharmacies
  • FDA Releases Two More Rules Implementing the Food Safety and Modernization Act
  • ZPICs and Skilled Nursing Facilities: Medicare’s Wild Wild West
  • Say Today, Pay Tomorrow: Florida Court Refuses to Enjoin Defamation
  • Ninth Circuit Interprets Fifth Amendment’s “Foregone Conclusion” Exception in IRS Summons Enforcement Case
  • Eleventh Circuit Holds Fair Debt Collections Act Requires That District Court Adjudicate Any Contested Ownership Interests In Property Subject To A Writ Of Execution
  • Switzerland’s Oldest Bank, Wegelin & Co., Pleads Guilty to Tax Violations, Agrees to Pay $74 Million to the United States
  • Class Action Lawsuits Attack Yogurt Products for Nonconformance with Standards of Identity
  • FDA Exhibits Increased Authority under Food Safety and Modernization Act
  • United States v. Caronia: Second Circuit Rules Manufacturers Cannot Be Criminally Prosecuted for Off-Label Promotion of Drugs Under FDCA
  • U.S. Lifts Ban on Imports from Burma: Continued Efforts to Ease Burma Back into the Global Economy
  • Kirtsaeng v. John Wiley & Sons:
  • Fourth Circuit Court of Appeals Upholds Federal Ban on Trafficking of Certain “Culturally Significant Articles”
  • Proposed Medicare Settlement Clarifies CMS’s Position on “Skilled Maintenance Services”
  • FDA Issues Draft Guidance and 510(k) Submission Checklist
  • FDA Issues Warning Letters to Manufacturers of Misrepresented Conventional Foods and Dietary Supplements
  • Medical Device Contract Manufacturers and Contract Sterilizers Now Required to Register and List
  • FTC and Brain-Pad Settlement Provides New Substantiation Standard and Highlights Issues with Enforcement of Consent Decrees on Non-Parties
  • The Regulation of Compounding Pharmacies Under Scrutiny Once Again
  • U.S. Indicts Multiple Companies and 165 Parties Added to the BIS Entity List for Alleged Involvement in Russian Military Procurement Network
  • Physicians and Pharmacies Must Be Aware of the Dangers and Potential Penalties Associated with Importing Prescription Drugs
  • Operation Pangea V: A Global Attack on Online Prescription Drug Pharmacies
  • The Corporate Solution to Texting While Driving
  • Medifast Agrees to Settle Advertising Dispute with FTC
  • FDA Warning Letters to Sprout Growers Highlight Complicated Legal Issues Associated with Warning Letters and Guidance Documents
  • FDA Releases CPG for Labeling and Marketing of Therapeutic Animal Foods
  • CBP Expands its Simplified Entry Program
  • Time is Money: CBP Proposes New Mitigation Guidelines for Liquidated Damages Response Petitions
  • CBP Changes Regulations for Suspected Counterfeit Merchandise
  • Florida’s Concurrent Cause Doctrine May Be a Valuable Tool to Overcome Insurance Policy “Intentional Acts” Exclusions
  • Eleventh Circuit Affirms Tax Court in Recharacterizing Loan as a Sale for Tax Purposes
  • Seventh Circuit: FBAR Forms Governed by Required Records Doctrine, Not Protected by Fifth Amendment
  • Update: Eastern District of New York Judge Finds Poker to be Game of Skill Not Chance Under Illegal Gambling Business Act
  • Class Action Lawsuits Allege Deceptive “Natural” Labeling Claims
  • Sixth Circuit Court of Appeals Vacates Sentence for Violating Constitution’s Ex Post Facto Clause
  • Federal Circuit Invalidates Section 263A Regulation Under the Chevron Test
  • Federal Appeals Court Affirms Collateral Consequences of Park Doctrine
  • IRS Win in Appellate Case Portends Bigger FBAR crackdown
  • FDA Clears Ingestible Medical Device through De Novo Review Process
  • U.S. Court of Appeals for the D.C. Circuit Affirms Son of Boss Accuracy-Related Penalty
  • FDA Targets Gastric Band Surgery Advertisements
  • Eleventh Circuit Rules that Tax Court Petition by Former owners Suspended the Statute of Limitations
  • FDA Issues Draft Guidance for Medical Device Pre-Submission Program
  • POM Wonderful and FTC Appeal Initial Decision
  • Drugmaker Sues FDA over Orphan Drug Exclusivity
  • FDA to Take Enforcement Action against Companies Marketing Unapproved Oxycodone Drugs
  • FDA Proposes Unique Device Identification System for Medical Devices
  • Florida Biotech Funding Tripled in 2011
  • Senate Passes Food and Drug Administration Safety and Innovation Act
  • Fourth Circuit Affirms Federal Tax Conviction
  • GlaxoSmithKline Agrees to $3 Billion Settlement to Resolve Fraud Allegations
  • FDA Denies Corn Sugar Petition, Only Sugar is Sugar
  • Tax Return Preparers Indicted for Assisting in Income Tax Evasion
  • FDA Announces Final Rule for Etched Citrus Labels
  • Third Circuit Affirms District Court Holding the Perlman Doctrine Inapplicable Criminal Tax Grand Jury Subpoena
  • U.S. District Court in Miami orders new trial based on discovery violation for Electronically Stored Information
  • Court Rebuffs FTC’s Attempt to Redefine “Competent and Reliable Scientific Evidence”
  • Eleventh Circuit vacates sentence in criminal tax case based on impermissible grouping under the U.S. Sentencing Guidelines
  • FDA Announces Delay in Compliance Deadlines for New Sunscreen Regulations
  • CMS Delays Data Collection by Manufacturers under the Physician Payments Sunshine Act Until January 1, 2013
  • Fifth Circuit reverses District Court and holds that taxpayer did not disclose listed transaction which extended the statute of limitations on assessment
  • Third Circuit Court of Appeals Affirms Trust Fund Tax Convictions
  • What Food Manufacturers Should Know about “Natural” Claims
  • “Fairness in Disclosure of Evidence Act of 2012” introduced as a Senate Bill in response to numerous Brady violations
  • Second Circuit Court of Appeals Reverses Convictions for Tax Evasion and Fraud
  • 59 individuals indicted in the Southern District of Florida in response to Medicare Fraud Strike Force investigation
  • IRS halts fraudulent tax refund scheme involving stolen identities and fake income tax returns
  • Joseph A. DiRuzzo, III OF Fuerst Ittleman convinces Third Circuit to reverse District Court regarding ineffective assistance of counsel allegations
  • IRS Commissioner Ignores Taxpayer Advocate’s Recommendations Seeking to Address Unduly Harsh Penalties Faced by Participants of the Offshore Voluntary Disclosure Program
  • Third Circuit Court of Appeals Affirms Decision Against Taxpayer Whose Check Was Incorrectly Processed
  • FDA Issues Draft Guidance on Use of Nanotechnology in Cosmetic Products
  • FDA Issues Draft Guidance on the Safety and Regulatory Status of Nanotechnology in Food
  • Centers for Medicare and Medicaid Services Urged To Issue Final Rule on Physician Gift and Disclosure Regulations
  • Fourth Circuit Creates Circuit Split in Virgin Islands Tax Case
  • FDA’s Import Trade Auxiliary Communication System (“ITACS”) Now Available
  • Foreign Corrupt Practices and International Trade
  • FDA Announces it Will Not Ban BPA
  • FDA Publishes “First-of-a-Kind” Guidance for Medical Device Premarket Approval and De Novo Decisions
  • IRS Bolsters Transfer Pricing Operations Unit
  • Update: Sackett v EPA: Supreme Court Declares EPA Compliance Orders “Final Agency Action” Subject to Judicial Review Under the APA.
  • Members of Congress Unhappy with FDA Draft Guidance entitled, “Dietary Supplements: New Dietary Ingredient Notifications and Related Issues”
  • U.S. District Court Strikes Down FDA’s Qualified Health Claim for Green Tea and Breast and Prostate Cancer
  • Park Doctrine Insurance Offered to Cover Responsible Corporate Officer Liability
  • Third Circuit Reverses Tax Court In Tax Exempt Interest Case
  • Tax Court Rules that U.S. Virgin Islands Partnerships are Corporations under “Check the Box” Regulations
  • Rise in Consumer Litigation Challenging Advertising and Labeling Claims
  • Third Circuit Court of Appeals Affirms Conviction for Tax Offenses
  • FDA Releases Factors for Determining High-Risk Status for Domestic Food Facilities
  • Update: Court Rules that FDA’s Graphic Smoking Warning Labels Violate First Amendment
  • Department of Justice Prosecutes for Failure to Remit Employment Taxes Collected From Employees
  • The Supreme Court Adds Tax Crimes under IRC §7206 to the List of Aggravated Felonies Requiring Deportation of an Offending Alien
  • Joseph A. DiRuzzo, III of Fuerst Ittleman petitions the Supreme Court of the United States for a Writ of Certiorari
  • U.S. District Court Rejects $50.2M Civil Penalty In False Claims Act Case
  • Florida Department of Revenue Issues Tax Warrant to the “Florida Supreme Court”
  • IRS Offers New Offshore Amnesty Program Amid Controversy
  • IRS’s Taxpayer Advocate Speaks Out Against the IRS
  • U.S. Department of Justice Indicts Swiss Bank Weglin & Co. for Assisting in Tax Fraud
  • Tax Court of New Jersey rules that single employee telecommuting from New Jersey is sufficient contacts to permit New Jersey to tax out of state business
  • FDA Denies Citizen Petition Seeking Mandatory NDA Labeling for Prescription Drugs
  • FDA Fines American Red Cross for Blood Safety Violations
  • Sackett v. EPA Highlights The Ongoing Debate Over What Actions Are “Final Agency Actions”
  • FDA Exempts Certain In Vitro and Radiology Devices from 510(k) Requirements
  • FDA Provides Guidance on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices
  • IRS announces 2012 voluntary disclosure program
  • IRS issues new Notice regarding “alter ego status”
  • Three Swiss Bankers Charged for Conspiracy to Defraud the United States by Helping Americans Keep Secret Foreign Accounts
  • U.S. Department of Justice Indicts U.S. Citizens Residing in the U.S. Virgin Islands for Bank Secrecy Act Violations and Tax Evasion
  • Justice Department Announces FCPA Charges Brought Against Former Siemens Executives
  • U.S. Tax Court Rules Against Taxpayer Who Received Multiple Tax Opinions
  • U.S. Department of Justice indicts taxpayer for FBAR violation and tax evasion
  • FDA and FTC Team up to Target HCG Weight Loss Products
  • Third Circuit Vacates Sentence of John M. Crim in Commonwealth Trust Company Tax Shelter Criminal Tax Case
  • FDA Issues Two Draft Guidances Regarding Investigational Device Exemptions
  • Merck Agrees to $950 Million in Fines for Unlawful Promotion of Vioxx
  • FDA Initiates Enforcement Against Dietary Supplement Manufacturer
  • 8th Circuit rules in favor of the Government of the U.S. Virgin Islands in Coffey v. Commissioner
  • FDA Issues Warning to Mylan Over CGMP Violations
  • IRS’s Voluntary Classification Settlement Program Ignores the Penalty Free Relief Available to Employers under Section 530 of the Revenue Act of 1978
  • Hill Dermaceuticals Sues FDA Following Approval of Generic Derma-Smoothe
  • 10th Circuit Dismisses Claims against FDA for Failure to Exhaust Administrative Remedies
  • FDA Issues SOP Aimed at Standardizing Data Requirements for Premarket Submissions
  • FDA Withdraws Approval of Breast Cancer Indication from Avastin Label
  • FDA Approves First Blood Product for Stem Cell Therapy
  • Bill Aims to Increase Number of Grandfathered Dietary Ingredients
  • WTO Finds Country of Origin Labeling a Technical Barrier to Trade
  • FDA Appeals Finding that it Lacks Power to Prohibit State-Licensed Veterinary Compounding
  • UFC Claims New York State Law Banning Live MMA Events Violates the First Amendment
  • Tax Court holds that use of foreign bank accounts provides basis for fraud exception to statute of limitations
  • Update: Court Issues Preliminary Injunction Blocking FDA’s Graphic Smoking Warning Labels From Going Into Effect
  • GlaxoSmithKline Agrees to Pay $3 Billion over Avandia Marketing
  • Third Circuit Court of Appeals Reverses Tax Court in Sunoco Inc. v. Commissioner of Internal Revenue
  • Senate Bill Seeks to Reinforce Least Burdensome Provisions for Medical Device Review
  • Seventh Circuit Finds State Consumer Protection Claim Preempted by Food, Drug and Cosmetic Act
  • Longest Prison Sentence to Date for Violations of the FCPA
  • Tax Court rules against corporate taxpayers who relied on advice from in-house professional
  • Tax Court Finds no “reasonable cause” for income omission where taxpayer provided information to and relied on tax return preparer
  • Bill Proposes to Change How FDA Reviews Medical Devices
  • Par Pharma Brings Suit Against FDA Over Promotional Claims
  • Company Pleads Guilty to Selling Misbranded Drug
  • U.S. Marshals Seize Detained Food under Authority of FSMA
  • FDA and CMS Launch Voluntary Parallel Review for Innovative Products
  • FDA Extends Comment Period for New Dietary Ingredient Draft Guidance
  • IRS Seeks to Reduce the Impact of Its Economic Substance Doctrine Field Directive by Stating it is Not Legal Precedent
  • Tax Court denies taxpayer’s attempt to recharacterize punitive damages as ordinary income
  • U.S. District Court Disallows $82 Million Refund Claim as Transaction was Tax Shelter
  • Fifth Circuit Court of Appeals affirms District Court’s determination that Partnership Was a Sham
  • Second DCA Asks Florida Supreme Court To Rule On Drug Statute’s Constitutionality
  • Recent Crackdown On “Commercial Marijuana Industry” A Concerted Effort By DOJ And IRS
  • Patent Reform Bill Restricts Patents on Tax Strategies
  • US Supreme Court to Rule on 6 Year IRS Audit for Tax Shelter
  • The IRS Requires Tax Preparer Fingerprinting
  • FDA Announces Enforcement Priorities
  • Del Monte Drops Suit Against FDA After FDA Lifts Import Alert
  • FDA Moves to Streamline De Novo Process
  • Scientists Appeal Ruling Allowing Federal Funding for Embryonic Stem Cell Research
  • Federal Prosecutors Take Aim At Corporate Officers For FDCA Violations With Revived Use Of The Park Doctrine
  • FDA Issues Letter to Industry Regarding Imports of Medical Devices
  • Patient Protection and Affordable Care Act Challenges Often Turn On Interpretation of the Court’s Commerce Clause Jurisprudence
  • IRS and DOL Release Final Regulatory Review Plans to Help Distressed Sponsors and Retirement Plans
  • Google Agrees to Forfeit $500 Million As Part of Non-Prosecution Agreement
  • FDA Announces Implementation of Traceability Projects under FSMA
  • 4th DCA Rules: Real Time Cell Phone Location Tracking Does Not Violate 4th Amendment
  • IRS Removes Two-Year Limit for Filing Innocent Spouse Claims
  • Bureau of Industry & Security Publishes Best Practices in Effort to Curb Illegal Export Transshipments
  • Researchers Find that Stem Cells May Prove Useful for Blood Transfusions
  • USDA Warns Public of Organic Certification Fraud
  • University of Miami Research Complex Paves Way for Biotech Companies in Miami
  • FDA Publishes Draft Guidance for Evaluation and Labeling of Scored Tablets
  • 11th Circuit Overturns Sanctions Levied Against Federal Prosecutors
  • Del Monte Prepares for Suit Against Oregon
  • FDA Issues Import Alert for Papayas from Mexico
  • Violation of FDA Regulations Prompts Seizure by U.S. Marshals
  • Del Monte Brings Suit Challenging FDA Import Alert
  • Facebook Changes Its Policy Regarding Pharmaceutical Companies’ Public Comment Walls
  • Five Tobacco Companies File Suit Challenging FDA’s New Warnings Rule
  • IRS Issues Guidance on Annual Fee Imposed on Branded Prescription Drugs
  • Arizona Naturopathic Doctor Pleads Guilty to Selling Stem Cells
  • FDA Denies Requests for Reconsideration
  • USDA Proposes Mandatory Livestock Tracking System
  • Johnson & Johnson Seeks Settlement in for Allegations of Off-Label Promotion of Risperdal
  • FDA Giving the Opportunity to Comment on Possible Changes to the 510(k) Process
  • FDA Announces Public Workshop for Medical Apps
  • Two Telecommunications Executives Convicted by Miami Jury on all Counts for their Involvement in Scheme to Bribe Officials at State-Owned Telecommunications Company in Haiti
  • U.S. Court of Appeals for the Second Circuit Overturns Gen Re and AIG Convictions
  • Court finds Florida’s Drug Abuse Prevention and Control Law Unconstitutional
  • More Than Half-Dozen Strains of E. Coli are Deadly, One is Illegal
  • FDA Requests Public Comment on Notification of a Health Claim or Nutrient Content Claim
  • FDA Announces Updates to Premarket Review Standards
  • FDA Seeks Comment on Food Safety Fees for Facility Reinspections
  • FDA to Launch Online Pet Food Tracking System
  • FDA Responds to Requests to Finalize Rule for Gluten-Free Labeling
  • New Head of Global Compliance Seeks Increase of FDA Authority over Drug Imports and Recalls
  • IRS Adds Income Section to Business Consultant Audit Techniques Guide
  • Congress Seeks to Clarify FDA’s Conflict of Interest Rules for Clinical Investigators
  • Main Street Fairness Act Draws Divided Reaction
  • USDA Proposes Rule to Establish Common Name for Raw Meat or Poultry with Added Solutions
  • FDA Issues Warning Letter to Makers of Muscle Milk for Mislabeling
  • Proposed Legislation for Dietary Supplement Labeling
  • FDA Sued Over Approval of Antibiotics in Animal Feed
  • D.C. District Court Rules Against Challenger of Embryonic Stem-Cell Funding
  • IRS Consolidates Transfer Pricing Programs and Bolsters International Coordination
  • IOM Report Suggests Overhaul of 510(k) Program; FDA Responds with Request for Public Comment
  • Tax Court Clarifies Deductibility of Long-Term Care Expenses
  • FDA Issues Draft Guidance for Mobile Medical Apps
  • USDA Considers Deregulation of Genetically Engineered Crops
  • FDA Urged to Ban Cephalosporin Use in Food Animals
  • FDA Issues Guidance Clarifying When Changes or Modifications to an Existing 510(k) Require New PMA Submission
  • Whistleblowers Claim Dialysis Company Deliberately Wasted Hundreds of Millions of Dollars in Medicine to Collect Medicare Overpayment
  • Beda Singenberger Charged with Swiss Account Conspiracy
  • U.S. Indicts Three Credit Suisse Bankers
  • Democratic Senator Challenges Tax Shelters and Offshore Havens
  • FDA Issues Draft Guidance for New In Vitro and Radiology 510(k) Exemptions
  • FSMA Checklist: Dietary Supplement Guidance and Anti-Smuggling Strategy
  • Patient Receives First Fully Synthetic Organ Transplant
  • FDA Proposes Guidance Document for In Vitro Companion Diagnostic Devices
  • Organic Labeling of Cosmetics under Scrutiny in California
  • Labeling Guidance Of Genetically Modified Food Gains Approval
  • Formaldehyde Containing Hair Straighteners Come Under Scrutiny, FDA Urged to Take Action
  • Researchers in Hong Kong Report “Super Cancer Stem Cells” Discovery
  • Sherley v. Sebelius: Briefs Argue Whether Federal Funds Incentivize Embryo Destruction
  • Brand-less Cigarette Labels in Australia
  • Bipartisan Support for Embryonic Stem Cell Legislation
  • Seven Major Pharmaceutical Companies File Citizen Petition Seeking FDA Guidelines Regarding Off-Label Information
  • IRS Sets Partnership, Estate and Trust Filing Extension at 5 Months
  • House Representatives Propose New Safe Cosmetics Act
  • FDA to Hear Avistan’s Appeal Regarding Proposed Revocation of Drug Approval
  • Strategies for Resolving Uncertain Tax Positions
  • Robert Becerra Presentation to National Assocation of Purchasing Management
  • Relaxed Restrictions for Tough “Innocent Spouse Relief” Rules
  • Supreme Court Holds Failure to Warn Suits Against Generic Drug Manufacturers Are Preempted By Federal Law
  • GAO Recommends Increased FDA Oversight of Medical Device Recalls
  • New Excise Tax for Medical Devices and Prescription Drugs
  • IRS Struggles to Deal with Increasing Tax Related Identity Theft
  • Swiss Officials Address Previous Fiscal Issues while Discussing the Implementation of the FATCA
  • IRS Guidance on the Offshore Voluntary Disclosure Program Likely to Increase Participation
  • Cuts in Food Safety Funding
  • FDA Releases Final Citizen Petition Guidance for Section 505(q)
  • Former Jenkens & Gilchrist Attorneys, Former BDO Seidman CEO, and Deutsche Bank Broker Found Guilty of Multi-Billion Dollar Tax Fraud Scheme
  • Federal Judge Permanently Enjoins HedgeLender From Promoting Its Stock-Loan Arrangement Which Allegedly Assisted Customers Evade Nearly 30 Million in Income Taxes
  • FDA’s New “Pathway” to Improved Monitoring of Food and Drug Imports
  • Notice 2011-55: IRS Partially Suspends FATCA Information Reporting Requirements
  • U.S. Cracks Down on UBS Clients in California
  • FDA Issues Final Rule On Cigarette Warnings And Unveils Nine New Graphic Warning Labels
  • FDA Announces Labeling Changes and Effectiveness Testing for OTC Sunscreen Products
  • Researchers Continue to Look to Stem Cells for Clues for Effective Treatments of Orthopedic Trauma and Blood-Related Disorders
  • Foreign Asset Reporting Update: IRS Releases Form 8938, FinCEN Grants FBAR Extension for Some Investment Advisors
  • IRS Releases Final Circular 230 Revisions Regulating Registered Tax Return Preparers
  • Panelists Address New Approaches to Increasing Efficiency of U.S. APAs
  • Third Circuit to consider Constitutionality of IRS Summons Issued in U.S. Virgin Islands Economic Development Credit Case
  • Third Circuit Court of Appeals overturns U.S. Tax Court regarding Virgin Islands Economic Development Program case
  • Two Dietary Supplement Companies Found Guilty of Criminal Contempt for Violating Consent Decree
  • IRS Prepares Enforcement Against at Least One Foreign Bank
  • AICPA Submits FBAR Comment Letter
  • IRS Relaxes Deadline for 2011 Offshore Voluntary Disclosure Initiative, Provides Opt Out and Removal Procedures
  • FDA Sued for Rescission of Menaflex’s 510(k) Clearance
  • IRS Devising Additional Guidance on UTP Reporting, Focusing on Reserves and NOLs
  • Foreign Bank Account Report (“FBAR”) Extended Filing Date Announced for Signatory Authority Only Filers
  • U.S District Court Judge Rebuffs IRS’ Attempt to Use “John Doe” Summons
  • U.S. Tax Court Rules in Favor of Good Faith Taxpayers
  • Improving the FDA Seafood Oversight Program
  • Recent DOJ Letters May Signal Increased Federal Efforts To Prosecute Medicinal Marijuana Under the CSA
  • FDA and Medical Devices Subject of Congressional Hearing
  • FDA Still Has Not Defined Gluten-Free After 3 Years
  • Proposed rulemaking by DEA will bring its regulations governing forfeitures in line with the Civil Asset Forfeiture Reform Act
  • All Induced Pluripotent Stem Cells (iPSC) Are Not Created Equal
  • IRS’s Second Guidance on the Foreign Account Tax Compliance Act (FATCA) Leaves Many Questions Unanswered
  • FDA Extends Comment Period for the Proposed Rule on Nutritional Labeling on Menus
  • The Internal Revenue Service Considers Taking a Closer Look at Political Donations
  • Department of Justice Prosecutes US Taxpayer For Failing to Report HSBC Bank Account in Bermuda
  • Drug Company Immunity A Possibility In North Carolina
  • DOJ Will No Longer Seek Chevron Deference for Revenue Rulings and Revenue Procedures
  • Senate passes Food Safety Crime Bill with greatly enhanced penalties
  • Induced Pluripotent Stem Cell Treatment Suffers a Setback
  • Former in-house counsel for GlaxoSmithKline acquitted
  • Second Patient Receives Embryonic Stem Cell Treatment in Gerons Clinical Trial
  • Court Dismisses Mylan Pharmaceuticals Lawsuit Over Lipitor Generic ANDAs On Standing and Ripeness Grounds
  • FDA Issues First New Rules under the Food Safety Modernization Act
  • Two Pharmaceutical Companies File Lawsuits in Response to FDA’s DESI Decisions
  • U.S. Patent and Trademark Office Grants Patents for Methods of Making Stem and Regenerative Cell-Enriched Fat Grafts
  • Sherley V. Sebelius: Federal Appeals Court Vacates Preliminary Injunction on NIH Funding for Embryonic Stem Cell Research
  • HCC Insurance Holdings, Inc. Reaches Settlement With OFAC Over Alleged Violations of Iranian Transactions Regulations.
  • Court Dismisses Drug Manufacturer’s Suit Against FDA Challenging Bioequivalence Regulations For Lack of Standing
  • FDA Modification to Dietary Supplement Qualified Health Claims Remanded by Federal Court
  • Companies Still Grappling with UTP Reporting Issues
  • United States Government Requests US District Court to Release Property Tax Records from California Board of Equalization
  • Federal Prosecution of Tax Crimes up 25%
  • Trouble For TaxMasters
  • U.S. District Court Grants Government’s Motion to Issue John Doe Summons to HSBC
  • Michigan lawmakers stir controversy proposing State Universities to report stem-cell use
  • Former GlaxoSmithKline in house counsel re-indicted
  • FDA Commissioner Testifies on FDA’s Screening Efforts at the Border
  • IRS Says Taxpayers Should Review Revised FBAR Instructions When Preparing Income Tax Returns
  • District Court Enforces Summons Issued to Taxpayer’s Attorneys
  • Ninth Circuit Rejects Government’s Hyper-Technical Interpretation of the Internal Revenue Code
  • More Medical Device Hearings in Congress Scheduled for This Week
  • Summary Judgment Granted to FDA in Challenge to Dietary Supplement Good Manufacturing Practices
  • United States Petitions Court for Leave to Issue “John Doe” Summons to HSBC
  • FDA Issues Nutritional Labeling Proposed Rule
  • Fair Value Measure Rules to be Issued in April by FASB, IASB
  • Shutdown Will “Severely” Limit FDA Inspections
  • Tax Court Adopts Daubert Standard for Expert Witnesses in Tax Court Trials
  • Government Persists with Efforts to End Marketing of “Cancer Cures”
  • FDA allows Pharmacy Compounding of Preterm Labor Drug
  • FDA Delays Federal Menu Nutritional Labeling Guidelines
  • Harsh sentences coming for strict liability FDA misdemeanor offense
  • FDA Updates the Import Entry Review Process for Medical Devices
  • US Government Audit Reveals Government Waste in Catfish Regulation
  • U.S. Supreme Court Rules That Drug Companies Must Report Adverse Events To Shareholders, Rejects “Statistically Significant” Risk Argument
  • Senators Urge the Federal Trade Commission to Examine Price Gouging of Drug for Pre-Term Labor Drug
  • FDA’s Tobacco Products Scientific Advisory Committee Says Ban on Menthol Cigarettes Would Benefit Public Health
  • FDA/McNeil Consent Decree Highlights Increased Government Efforts At Regulating Drug Recalls
  • Stem Cell Research Flourishes Abroad
  • Senate Passes the America Invents Act Promoting Taxpayer Rights at the Expense of Intellectual Property Rights
  • Movie Theaters and Grocery Stores fight Calorie Disclosure Rule
  • FDA Considering Enhanced Regulation or Ban On Menthol Cigarettes
  • FDA To Take Over Three Tylenol Manufacturing Plants As Part Of Consent Decree
  • Tax Court’s Ruling in Canal Corp. v. Commissioner calls into question the ability to rely on formal tax opinions
  • 11th Circuit Affirms Conviction in Tax Fraud Case Under 18 U.S.C. section 286
  • New Test Shortens Time for Determining Pluripotency of Stem Cells
  • FDA Takes Cooperation with FTC to a New Level
  • Court of Appeals Overturns Ruling Allowing FDA to Conduct Records Inspections of Compounding Pharmacies
  • U.S. Department of Justice charges former UBS banker Christos Bagios with conspiracy to defraud the United States
  • Supreme Court limits the Confrontation Clause of the Sixth Amendment in Michigan v. Bryant
  • FDA Announces Removal of Unapproved Cold, Cough, and Allergy Drugs from U.S. Market
  • President Obama Warns FDA That Overhaul and Modernization Are Necessary
  • New Food Safety Law Contains Protections for Whistleblowers
  • Final FASB Guidance on Troubled Debt Restructurings Due Out by March 31, 2011
  • U.S. Supreme Court to Decide if Internal Revenue Code Section 7206 Offenses are a Basis for Deportation
  • FDA Food Safety Modernization Act Adds Requirements for Grocery Stores
  • Tax Court Rules in Favor of Taxpayers in Foreign Tax Credit Cases
  • United States Tax Court Denied Motion to Interplead the Government of the Virgin Islands Regarding Tax Credits Under the Virgin Islands Economic Development Program
  • 4th Circuit Rules in Favor of Taxpayers in Son of Boss Case in Home Concrete v. United States
  • House Ways And Means Committee Approves Repeal Of Expanded Form 1099 Provisions
  • E-Cigarette Distributor Sues to Stop FDA from Preventing the Importation of Electronic Cigarettes
  • New Bill Seeks to Limit the Way Manufacturers Handle Recalls
  • Swiss Bankers Indicted in Virginia by Department of Justice Tax Division for aiding tax evasion
  • FDA to Unveil Rules for Reviewing Biosimilars “Very Soon”
  • Fifth Circuit Rules against the United States in basis overstatement case – causing further rift between the Circuits in Son of BOSS cases
  • IRS Announces Second Special Offshore Voluntary Disclosure Initiative (OVDI)
  • Florida’s Fourth District Court of Appeal Expands Definition of “Salaries or Wages” to Include Commissions
  • NOAA Seeks to Expand Aquaculture to Increase Consumption of Domestic Seafood
  • Medical Device Manufacturers Seek Quick Approval Overseas
  • FDA Announces Availability of “Medical Device Innovation Initiative” Report for Public Comment
  • FDA Releases Criteria For Criminal Prosecution Under Park Doctrine
  • Swiss Government invokes Mutual Legal Assistance Treaty in fraud investigation of Miami businessman
  • Tax Court Holds for Taxpayers – Upholds Use of Limited Liability Company to Generate Tax Credits
  • Court Of Appeals Widens Circuit Divide on Basis Overstatement as to the Six Year Statute Of Limitations
  • South Florida Residents Sentenced To 10 Years
  • Seizures of Counterfeit Goods a Priority for CBP
  • Fourth Circuit Dismisses Challenge To Federal Embryonic Stem Cell Research Funding Citing Lack Of Standing Of Challengers
  • Federal Judge Finds that Rule 30(b)(6) Depositions Go Beyond Listed Subjects
  • GAO Suggests that FDA Shift Gears Regarding Health Claims in Food Labeling
  • Seafood Executives Plead Guilty to Selling Mislabeled Fish
  • Discovery Violations Result In Judge Striking Defenses in DuPont’s Benlate Pesticide Litigation
  • Hyperbaric Clinic Reopens Amidst Controversy
  • FDA Begins Overhaul of 510(k) Process
  • FDA Seeks to Rid the Market of Unapproved Cough, Cold, and Allergy Drugs
  • Virgin Islands Economic Development Commission taxation issues escalate to the Third Circuit Court of Appeals
  • United States Tax Court Opines on its own Jurisdiction to Resolve USVI Tax Issues
  • Funding Needed to Make Food Safety a Reality
  • FDA Seeks to Rid the Market of Unapproved Cough, Cold, and Allergy Drugs
  • USDA Issues Draft Guidance Concerning Organic Labeling
  • Enforcement Emphasis on Employee Classification is Likely to Decrease Payroll Tax Evasion
  • The IRS Indicates a Second Voluntary Disclosure Program for Offshore Assets is “Very Likely” But Continues to Remain Silent on its Terms
  • FASB Clarifies Coming Guidance on Balance Sheet Offsetting
  • National Taxpayer Advocate Report Reveals the IRS’s Lack of Sympathy for Financially Struggling Taxpayers
  • Advocacy Groups Push for “Humane” Labeling
  • Joe Diruzzo of Fuerst Ittleman petitions United States Supreme Court for Writ of Certiorari
  • Subsequent Remedial Measures Not Admissible in Contract Cases
  • IRS Disagrees with TIGTA Report That Finds IRS Control Procedures and Employees To Be Ineffective
  • Venue Defense is Waived if Not Raised in Initial Rule 12 Motion in Response to Complaint
  • FDA Clears Aldagen to Test Stem Cell Treatment for Strokes
  • Florida Attorney General centralizes anti-pill mill initiative in West Palm Beach
  • FDA Clears the Way for New Embryonic Stem Cell Trial
  • Investments to Medical Device Firms Hindered by FDA
  • New British Bribery law will mean trouble for American pharmaceutical firms
  • IRS Finalizes Regulations Requiring Corporations to file Uncertain Tax Position Statements
  • Work Product, Tax Accrual Workpapers & the IRS
  • Latest developments in the Pharma lawyer obstruction of justice case
  • Alcatel-Lucent to pay $137 million to settle Justice Department Foreign Corrupt Practices Act lawsuit
  • Produce Recalled After Testing Positive for Salmonella
  • Former executives of Latin Node, Inc. charged with FCPA violations for bribing Honduran government officials
  • Justice Department Announces Plea Agreement in UBS Case
  • Consumers Skeptical of “Natural” Products
  • FDA Targets Tainted Dietary Supplements
  • Former UBS Banker Pleads Guilty to Defrauding the United States by Helping Conceal Assets Offshore
  • House Turns its Attention to Drug Safety
  • IRS Seeks to Prevent Future Errors on Tax Returns by Focusing on Return Preparers
  • The IRS’s Rejects Judicial Interpretations of the Six Year Statute of Limitations Rule
  • FDA Targets Tainted Dietary Supplements
  • Embryonic Stem Cell Research Largely Funded by States
  • Dannon Agrees to Settle Advertising Dispute with the FTC
  • Key Elements of the Food Safety Modernization Act of 2010
  • With Offshore Tax Evasion an IRS Top Priority, Practitioners Seek Extension of Voluntary Disclosure Program
  • Victor Stanley, Inc. v. Creative Pipe, Inc. A Lesson in the Consequences of Spoliation of Evidence
  • Revision to Federal Rule of Civil Procedure 26 Broadens Work Product Protections for Expert Communications with Attorneys
  • Three Pharmaceutical Manufacturers Agree To Pay $421.2 Million In False Claims Act Settlement
  • Treasury Department Moving Closer to Finalizing Rules on COD Income for Partnerships
  • FDA Publishes Agenda for Upcoming Guidance Documents
  • McNeil Brings Failure-to-Warn Preemption Issue to Supreme Court
  • IRS Issues PMTAs Regarding Financial Data Requests At CDP Conferences, Lien Discharge in Short Sale Situations
  • Senate Rejects Amendments To Repeal 1099 Rules From Health Care Reform Bill
  • U.S. And Panama Sign Tax Information Exchange Agreement
  • Stakeholders Seek Additional Clarifications From IRS In Wake Of Its Initial Guidance On FATCA
  • IRS Withdraws “John Doe” Summons Against UBS
  • FDA Clearance of New Embryonic Stem Cell Clinical Trials and Upcoming Arguments in Federal Court of Appeals
  • Mitchell Fuerst Presents Webinar on Year-End Tax Planning for CFOs
  • Physicians’ Ties With Pharmaceutical Companies: Down, but not out
  • Recent Action Against Caffeinated Alcoholic Beverage Manufacturers Highlights The Dual Jurisdiction Of FDA and TTB In Federal Labeling Issues
  • FDA Releases Detained Shipment After Company Brings Suit
  • Freight Forwarder and Oil Service Companies Pay Huge Fines For Violating The Foreign Corrupt Practices Act
  • Pharmaceutical Company Lawyer Indicted For Obstructing FDA Investigation Into Promotions of Unapproved Uses of Prescription Drug
  • IRS Reaffirms Respect for Attorney-Client Privilege in Schedule UTP Disclosures
  • Schedule UTP Disclosures Will Put New Companies in the Sights for an IRS Audit
  • Internal Revenue Service Office of the Chief Counsel Carves Out Narrow Exception for Properly Applied First Sale Rule in Customs Law
  • Taxpayer Advocate Service Recommends IRS Change Mission Statement to Reflect New Expanded Role
  • Whistleblower Lawsuit Results in $750 million Settlement for GlaxoSmithKline
  • Lame Duck Congress Addresses Expiring Bush-era Tax Cuts, the Alternative Minimum Tax, and Tax Reform for the Upcoming Tax Year
  • FDA Releases Guidance for Cellular Therapy Sponsors
  • Mitchell Fuerst Featured Speaker at Upcoming Stem Cell and Age Management Medicine Conference and Meeting
  • New Clarification on UTP Disclosures from the IRS
  • McConnell Says Republicans Must Block Obama Tax Hikes
  • Tea Party May Throw Kink Into GOP Trade Policies
  • 2,923 Small Biotechnology Companies to Receive $1 Billion in New Therapeutic Discovery Project Credits and Grants
  • U.S. Attorney’s Office For the Southern District Of Florida Increasing Training And Expanding To Combat Fraud
  • Arizona Aviation Company Indicted for Violating Arms Export Control Act
  • Can 5,783 People and Businesses be Wrong? IRS Inundated with Comments on Proposed Tax Preparer Regulations
  • Florida Ranked #5 Nationally in Business Tax Climate
  • CBP Loosens the Reigns on Information Sharing for Customs Brokers
  • FDA Embarks on New “Swift and Aggressive” Enforcement Approach
  • Cargolux Executives Indicted In Rate Fixing Conspiracy
  • FTC maintains momentum in dietary supplement regulation
  • IRS Commissioner Introduces the Return Preparer Initiative
  • Requesting a Private Letter Ruling on Uncertain Tax Positions? You may have to Wait for Guidance Instead
  • CBP loses court case on enhanced bonding requirements for shrimp importers.
  • New Schedule UTP Finalizes Guidance on Uncertain Tax Positions and FASB Interpretation No. 48
  • FDA Announces Public Meeting on Approval Pathways for Biosimilars
  • CVS To Pay Largest Civil Penalty Ever Under The Controlled Substances Act for Unlawful Sales of Pseudoephedrine
  • More News on the Coming Wave of FDA Enforcement Actions
  • FDA Message to Pharma: Misdemeanor Criminal Charges can Result from Promoting Off-Label Drug Uses
  • Brazilian Regulations List Delaware as a Tax Haven
  • Codification of the Economic Substance Doctrine is Not a Change in Substantive Law
  • “Oh yeah?!” PCAOB Bars Foreign Auditors which do not Allow Board Inspections
  • Separate but Equal – AICPA Panel Recommends a Separate Board to Establish Private Company Accounting Standards
  • Nestle Announces Creation of Food Sciences Institute In Wake Of Federal Trade Commission Settlement
  • Medicare To Implement New Billing Procedures, Proposes New Regulations To Combat Fraud
  • CBP Withdraws Proposed “Last Sale” Rule
  • POM Sues FTC over New Substantiation Standard for Food and Dietary Supplement Claims
  • FDA and CMS Consider Parallel Review of Medical Products
  • Oprah And Rachel Ray Assist The Federal Trade Commission In Taking Down Allegedly Deceptive Acai Marketers
  • Willful Blindness Jury Instruction Upheld In Tax Conviction
  • Allergan Pleads Guilty To Misbranding Charge Agrees To Pay $600 Million In Fines And Penalties
  • Forest Pharmaceuticals To Plead Guilty For Food, Drug, And Cosmetic Act Violations
  • FDA Cracks Down On Nutrition And Health Claims By Green Tea Makers
  • Mitchell Fuerst Comments on Proposed FASB Standards
  • OFAC Begins Process Of Lifting Sanctions In Post-War Iraq
  • FDA Closer To Approving Genetically Modified Salmon
  • FDA Begins Crackdown On E-Cigarette Industry Announces Intent To Regulate E-Cigarettes
  • J&J could face further regulatory action if intent of GMP violation proven – attorneys
  • Phone Companies Urge US Government To Loosen Telecommunications Regulations For Cuba
  • Distinguished Orthopaedic Surgeon Joins NeoStem’s Medical Advisory Board
  • Federal Prosecutors Drop Charges Against Former Westar Executives
  • FDA Busy Crafting Calorie Court Regulations
  • Drug Recalls Increase 309% in 2009
  • Justice Sandra Day O’Conner sides with a Small Business Against the IRS
  • Pistachios in a Pinch
  • Health Care Reform Strengthens Fraud Prosecutions and Expands Scope of False Claims Act
  • Dietary Supplement Marketer to Pay $5.5 Million to FTC for Weight Loss and Immunity Claims
  • Senate Bill Introduced to Increase FDA Authority
  • IRS Successfully Prosecuting Tax Evaders
  • Feds Challenge Stem-Cell Treatment
  • Colorado Medical Clinic Welcomes Opportunity to Fight FDA in Court
  • IRS Liens go Un-noticed
  • Money Laundering charges now require proof that a transaction has the purpose of concealing illegal monies
  • When Export “Classification Determinations” do not Determine Anything At All
  • FDA Clears First Embryonic Stem Cell Trial Using Patients to Begin
  • HSBC is New Target of DOJ Investigation into International Banks and Tax Evasion
  • FDA approves generic Lovenox® (enoxaparin) representing a major policy advancement for naturally-sourced generic drugs and possibly biosimilars.
  • FDA Issues Notice for Voluntary Registration for Non-Covered Retail Food Establishments and Vending Machine Operators Electing to Opt-In to Coverage of the Nutritional Disclosure Requirements of the Patient Protection and Affordable Care Act of 2010
  • New Physician Gift and Disclosure Reporting Rules that Drug and Medical Device Manufacturers Should Know
  • Tax Dodgers Beware: New Foreign Account Tax Compliance Legislation
  • DC Circuit Court Allows “Rivals” in Research who are Competing for Federal Grants to Challenge Agency Actions that Benefit Their Opposition
  • Medicare Fraud of $251 Million, 94 Suspects Indicted
  • Safe Cosmetics Act of 2010: New Bill Would Increase Cosmetics Regulations
  • Indoor Tanning Industry under FDA and IRS Scrutiny
  • “Theft of Honest Services” Fraud Statute Narrowed by Supreme Court
  • IRS Associate Chief Counsel Musher on FATCA Guidance, Withholding,
  • Qualified Health Claim Approval May become easier for Dietary Supplement Marketers
  • Miami-Based Trade is Booming (So is Enforcement)
  • UBS Deal with U.S. Threatened by Vote in Swiss Lower House
  • Severe Tax Penalties to be Imposed for Violation of Newly Codified Economic Substance Doctrine
  • New Healthcare Program Gives $1B in Tax Credits and Grants for Small Pharmaceutical and Medical Device Firms
  • What Chain Restaurants and Vending Machine Operators Need to Know About New Federal Law Requiring Nutritional Disclosure on Menu and Menu-Boards
  • Government Accountability Office Issues Report On Herbal Supplement Marketing
  • Fuerst Ittleman Sponsors the University of Florida’s College of Agriculture and Life Science 8th Annual Golf Tournament
  • ANN TAYLOR ESCAPES FTC ENFORCEMENT ACTION
  • FDA Seeks Comment on Draft Guidance for Industry, Third Parties and FDA Staff; Medical Device ISO 13485:2003 Voluntary Audit Report Submission Program
  • Kansas City CPA and Attorney Barred from Promoting Tax Fraud Schemes
  • South Carolina Tax Preparer Fabricated Returns and Directed Refunds to Bank Accounts She Controlled
  • Compounding Pharmacist Gains Partial Judicial Relief; Still Guilty on Eight
  • Spring Treasury Regulatory Agenda
  • Regenerative Medicine to Grow to a $20 Billion Industry in 15 Years
  • New Indictments, Arrests in Multi-State Health Care Fraud Scheme
  • Court Authorizes Refund of EU Retaliatory Duties
  • Healthcare Fraud Crackdown Expanded in Miami-Dade County
  • U.S.-Swiss Tax Treaty Amendments: Stricter Cooperation and Enforcement on the Horizon
  • IRS Considers Oversight of Tax Return Preparers
  • Food Safety Legislation Update
  • Scientific Developments in Induced Pluripotent Stem Cells
  • The IRS Targets Taxpayers Hiding Assets in Offshore Bank Accounts
  • Orthopedic Implant Companies Out of Fed Oversight
  • Madoff Investors Getting Some Relief from IRS
  • Federal Agencies Publish “Good Importer Practices”
  • New CBP Penalties for Export (AES) Violations
  • A Rosa gallica by any other name?USDA Levies New Requirements on Imported Plants and Plant Products
  • A Happy, and More Secure, 2009
  • International Business Leadership Award 2008
  • FDA Food Protection Plan
  • Fuerst Ittleman Blog
  • Category: Government Compliance
    • Category: FDA
    • Category: Healthcare
    • Category: International Trade and Customs
    • Category: Money Services Businesses
      • Operation Choke Point Update: Despite Congressional and Industry Criticism, DOJ Will Continue Crackdown On Payday Lending Industry
  • Category: Litigation
    • Bitcoin Update: Recent Decision May Provide Roadmap for Calculating Damages Associated with Bitcoin Related Litigation
    • Category: White Collar Defense and Investigations
  • Category: Tax Law
    • Category: Anti-Money Laundering
      • FTC Settlement with Payment Processor Highlights Importance of Anti-Money Laundering Programs for Non-Bank Financial Institutions
      • Corporate Compliance Officers Face Threat of Civil Monetary Penalties and Criminal Prosecution for Institutional AML Deficiencies
      • Choked Out: Operation Choke Point seeks to eliminate financial services for “high risk” businesses
      • Despite FinCEN and Department of Justice Guidance, Difficulties Remain for Financial Institutions Providing Services to Marijuana-Related Businesses
      • Casino AML Compliance Update: Las Vegas Sands Corp. Places Macau Casino Junkets Under Increased Scrutiny.
      • Anti-Money Laundering Compliance Update: FinCEN Guidance Regarding Banking Marijuana-Related Businesses Raises Many Questions, Answers Very Few
      • Anti-Money Laundering Compliance Update: FinCEN Issues Guidance For Financial Institutions Providing Services To Marijuana-Related Businesses
      • Bitcoin Regulatory Update: FinCEN Publishes Administrative Rulings Further Clarifying When Virtual Currency Activity Constitutes Money Transmission
      • Charlie Shrem And Why We Need To Change Our Perspective Of Bitcoin
      • CFPB Proposes To Regulate Large International Money Transfer Providers
      • Update: Crackdown on Casino AML Deficiencies Continues as Caesars Entertainment Corp. becomes subject of FinCEN and DOJ Investigation
      • United States v. Lang: Eleventh Circuit Clarifies How Structuring Violations Must be Pled in Federal Criminal Cases
      • Las Vegas Sands Casino Money Laundering Settlement a Bellwether for Future Cases
      • Update: “Marijuana Businesses Access to Banking Act of 2013” proposed in Congress to ease burdens associated with providing banking services to marijuana-related businesses
      • Export Compliance Update: OFAC Issues General License Easing Restrictions On Exportation Of Communications Services, Software, and Hardware To Iran
      • Announcing the Fuerst Ittleman David & Joseph Mini-Blog
      • Bitcoin Regulatory Update: Understanding the Federal Government’s Attack on Mt. Gox
      • Update: Florida Legislature Adopts OFC Workers’ Compensation Fraud Work Group Recommendations, Passes Law Establishing Real-Time Check Cashing Database and Check Casher Reporting Requirements
      • Queen Shoals Ponzi Scheme Defendant Pleads Guilty
      • Senate Committee on Banking Holds Hearing on Lax Enforcement of the Bank Secrecy Act
      • Update: Third Party Payment Processor Sentenced to Jail Time for Processing Internet Poker Company Funds
      • Update: Online Poker Executives Guilty Plea Highlights the Additional Penalties Payment Processors When Processing Illicit Gambling Proceeds
      • Update: Workers Compensation Fraud Task Force Announces Multiple Arrests in Workers Compensation Check Cashing Scheme
      • Update: Online Poker Sites Reach Settlement With Justice Department Over Fraud Allegations; Payment Processor Associated with Online Poker Fraud Sentenced
      • Senate Report Reveals Numerous Sustained AML Deficiencies at HSBC
      • Consumer Financial Protection Bureau Seeks Comments Regarding General Purpose Reloadable Prepaid Cards
      • Lawyers fired, Bank recants testimony after it is discovered that Bank altered document used at federal trial
      • Electronic Check Processing Under Increased Scrutiny By U.S. Bank Regulators Because Of Increased Risk of Money Laundering
      • FinCEN Issues Guidance On Currency Transaction Reporting For Businesses With Common Ownership
      • FinCEN Issues Advisory To Financial Institutions Regarding SAR Confidentiality
      • 11th Circuit Court of Appeals Decision Regarding “Act of Production” Doctrine Has Implication for Bank Secrecy Act and Foreign Bank Account Report (FBAR) Cases
      • FinCEN Issues Advisory To U.S. Financial Institutions Regarding Providing Financial Services to Foreign-Located MSBs
      • FinCEN Final Rule Requires AML Programs and SAR Filing for Non-Bank Mortgage Lenders and Originators
      • Bill Introduced In Florida House Of Representatives Is Designed to Combat MSB Facilitated Workers’ Compensation Fraud
      • New Iranian Sanctions May Lead to Uncertainty for Foreign Financial Institutions Engaging in Business in Iran
      • Absolute Poker Co-Owner Pleads Guilty To Conspiracy To Violate UIGEA, Wire Fraud, And Mail Fraud In Connection With Internet Poker Site Operation
      • Two Attorneys Arrested and Charged with Structuring Transactions to Avoid Bank Secrecy Act Reporting Requirements
      • Congressmen Call For Investigation of Two U.S. Companies for Possible Syrian Sanctions Violations
      • Office of Financial Regulation’s MSB Facilitated Workers’ Compensation Fraud Work Group Issues Report and Recommendation to Florida House; Draws Criticism from Legislators.
      • Second Circuit Overturns Conviction for Violation of Iranian Transactions Regulations and Operation of an Unlicensed Money-Transmitting Business
      • OFAC Announces Settlement With JPMorgan Chase Bank N.A. For Multiple Violations
      • Office Of Financial Regulation Report Finds That Money Services Businesses Help Facilitate Ongoing Workers’ Compensation Premium Fraud
      • World-Check Comments On Money Laundering Risk Presented By Venezuela
      • FinCEN Releases Final Rule Clarifying Money Services Businesses Definitions, Includes Foreign-located MSBs Doing Business in U.S.
      • General Reinsurance Corp. Settles With OFAC Over Alleged Violations of Iranian Transactions Regulations
      • Consumer Financial Protection Bureau Seeks Public Comment To Help Shape Nonbank Supervision Program
      • FinCEN Expected to Announce Final Rule On Pre-Paid Access Cards In July 2011
      • Department of Justice Shuts Down Three of the Largest Internet Poker Sites in US, Charge Owners with Unlawful Internet Gambling, Fraud, Money Laundering, and Seek to Recover $3 Billion in Civil Penalties.
      • New York Clarifies Position On Licensing Of Internet Based Money Transmitters
      • U.S. Attorney Seeks $7 Million In Forfeiture Trial Of Privately Printed “Liberty Dollars”
      • FinCEN Amends and Clarifies FBAR Responsibilities
      • FinCEN Issues Guidance To Financial Institutions On Ongoing Events In Libya
      • Ocean Bank to Pay Fine for Bank Secrecy Act Violations
      • FinCEN Issues Guidance To Financial Institutions On Recent Events In Egypt
      • Federal Prosecutors Focus On Payment Processors In Latest Effort To Prevent Online Poker Sites From Operating
      • FinCEN Proposed Rule On Cross-Border Electronic Transmittal Of Funds Reporting Requirements Draws Criticism From Banking Community
      • Civil Suit Seeks to Hold Bank Liable for Haitian Ponzi Scheme
      • FinCEN Assessment of Civil Monetary Penalty Against Unlicensed Money Transmitter Reveals the Importance of Compliance with Federal Regulations
      • EU Ministers Agree to Legislation Aimed At Ending Bank Secrecy Laws of Member States
      • FinCEN Proposes AML Plan for Non-Bank Mortgage Lenders and Originators
      • Pinnacle Aircraft Parts, Inc. Reaches Settlement With OFAC For Violation Of Reporting, Procedures, And Penalties Regulations
      • US Department Of The Treasury Continues Its Implementation Of Tougher Sanctions Against Iran
      • FinCEN Proposes Reporting Regulations For Cross-Border Electronic Transmittals Of Funds By Financial Institutions
      • $30 Million Seized From Vatican Bank In Money Laundering Probe
      • U.S. Government successfully forfeits $13 .3 million from online poker sites
      • Department of Treasury Releases Updated Guidance To Financial Institutions On Informal Value Transfer Systems
      • Banco Colpatria, S.A. Settles Narcotics Trafficking Sanctions Violations
      • Barclays Bank PLC Reaches Settlement With US Authorities
      • Newly Released Mexican Regulations Imposing Restrictions on Mexican Banks for Transactions in U.S. Currency
      • Miami Medicare Fraud Ring Linked to Check Cashing Stores
      • Harsh Sentence for Miami Check-Cashing Store Owner
      • Fuerst Ittleman Assists Clients and Earns a “Thank You”
      • Foreign Bank Accounts and the IRS
    • Category: Corporate and Business Law
    • Category: Tax Litigation
    • Category: Wealth Preservation and Tax Planning
• Category: Christopher David
  • Nursing Home Patient’s Family Can’t Revive Axed Jury Win
• Category: Firm News
  • Why the Chipotle criminal probe shouldn’t be surprising
  • Andrew Ittleman, Speaker at Latin American Bitcoin Conference
  • Andrew Ittleman, Panelist at FDLI Enforcement Conference
  • Press Release: Fuerst Ittleman David & Joseph, PL is pleased to announce that Joseph A. DiRuzzo, III, has been Board Certified by the Florida Bar as an expert criminal appellate attorney.
  • Fuerst Ittleman David & Joseph PL is pleased to announce that they are a contributing sponsor of the Fourth North American Bitcoin Conference
• Category: General
• Category: In the News
  • Giving or Receiving a Down Payment Gift? Here Are the Tax Consequences
  • Taxes on life insurance: Here’s when proceeds are taxable
  • Will the OECD reach a digital tax consensus?
  • How These Fortune 500 Companies (Legally) Paid $0 In Taxes Last Year
  • Are You Eligible for Tax Savings with the Home Office Deduction?
  • Top 27 Business Tax Saving Tips from the Pros
  • DOJ Changing of the Guard Could Impact Corporate Compliance
  • What Barclays’ Africa Pullout Means for De-Risking Phenomenon
  • Practical Applications of the Yates Memorandum for the U.S. Food Industry
  • Defense attorney challenges Gomez’s standing
  • U.S. Data from Swiss Banks May Mean More Prosecutions
  • The Female Attorneys You Admire
  • Hectic Trial Schedule May Have Forced $100M Engle Deal
  • Asymmetrical Reporting: A Trap for the Unwary
• Category: Jeffrey Molinaro
• Category: Jennifer Correa
• Category: Jessika Tuazon
• Category: Micheal Kornhauser
• Category: Mitchell Fuerst
• Category: Thomas David
• Category: Uncategorized

Events

• Andrew Ittleman to Host IMTC WORLD 2015
• Joseph DiRuzzo III will be speaking on “Tax Planning with the U.S. Virgin Islands and Puerto Rico
• Mitchell Fuerst presents “How to Avoid Criminal Exposure in the New Regime of IRS Compliance Reporting Requirements”
• Andrew Ittleman will speak on the topic Banking Marijuana
• Evento 2
• Fuerst Ittleman David & Joseph PL is pleased to announce that they are a contributing sponsor of the Fourth North American Bitcoin Conference

Practice

• Appeals and Trial Support
• FDA Establishment Registration
• FDA Enforcement Actions: Warning Letters and Untitled Letters
• Compounding Pharmacies
• DOJ Yates Memorandum
• United States Virgin Islands Tax Law and Litigation
• International Arbitration
• Biologics
• Cosmetics
• Animal and Veterinary Products
• Food, Beverages, and Dietary Supplements
• False Claims Act Litigation
• Class Action Litigation
• Criminal Appeals
• Import and Export of FDA- Regulated Products
• Corporate Transactions
• Corporate Contracts
• Corporate Governance and Compliance
• Entity Formations
• Start-up Companies
• General Corporate Matters
• Corporate Business Transactions
• Corporate
• Virtual Currencies Compliance
• Compliance for Casinos
• International Business Transactions
• Trade Litigation
• Export Disputes and Enforcement
• Sanction Programs
• Management of Export Controls
• Export Compliance Matters
• Export Controls
• Import Disputes and Enforcement
• Compliance Audits and Self-Assessment
• Duty Management
• Import Management and Planning
• Import Compliance
• Customs and Import Compliance
• HIPAA
• FIPA
• Anti-kickback Regulatory Compliance
• Surveys & Deficiency Citation Appeals
• STARK Regulatory Compliance
• Outside General Counsel
• Medicare Overpayment Appeals
• Home Health Agency Regulatory Compliance
• Stem Cells and Regenerative Medicine
• Medical Devices
• Medical Tourism
• Food, Drug and Life Sciences Practice Group
• Prescription Pharmaceuticals
• Advertising and Consumer Law
• Food & Drug Law
• Asset Forfeiture
• Mail Fraud and Wire Fraud
• Healthcare Fraud
• Unlicensed Money Transmitting Business
• Money Laundering
• Misdemeanor FDCA Violations and the Park Doctrine
• Misbranding Violations
• Adulteration Violations
• FDA Criminal Defense
• Criminal Tax Defense
• Bank Fraud
• White Collar Defense
• Complex Commercial Litigation
• Tax Compliance
• State and Local Taxation
• Real Estate Tax Planning
• Managing the Tax Impacts of Business Transactions
• EB-5 Immigrant Investor Visas
• Voluntary Disclosures
• Federal Tobacco and Excise Taxes
• Tax Planning
• Tax Exempt Organizations
• Government Agency Litigation
• Money Services Businesses
• Healthcare
• International Trade and Customs
• Anti-Money Laundering
• Tax Litigation (Controversy and Dispute Resolution)
• Tax Law
• Litigation
• Government Compliance

People

• Namrata Joshi
• Joshua Salmon
• Strategic Alliances
• Marielys Rosado Barreras, CPA, LLM
• Chris Rajotte
• Jeffrey Molinaro
• Michael B. Kornhauser
• Gerson M. Joseph, Of Counsel
• Allan A. Joseph, Partner
• Christopher M. David, Partner
• Andrew S. Ittleman, CAMS, Partner
• Mitchell S. Fuerst
  (in memoriam 1953-2016)
• Jennifer Correa Riera

Map Location

• Virginia
• Vietnam
• Caracas
• Venezuela
• Valencia
• Vanuatu
• Salt Lake City
• Montevideo
• Turks and Caicos Islands
• Turkey
• Tunisia
• Thailand
• Syria
• Sweden
• Staten Island
• St. Vincent and the Grenadines
• St. Thomas
• St. Lucia
• St Louis
• South Korea
• Greenville
• South Africa
• Singapore
• Seychelles
• San Diego
• Montreal
• San Juan
• Polk
• Poland
• Philippines
• Philadelphia
• Lima
• Pennsylvania
• Pakistan
• Oregon
• Toronto
• Mississauga
• Cleveland
• North Carolina
• Nigeria
• Nicaragua
• New Zealand
• Valley Cottage
• Albany
• Farmingdale
• Nevis
• Netherlands
• Netherland Antilles
• Morocco
• Billings
• Monroe
• Missouri
• Michigan
• Merida
• Mexico City
• Mauritius
• Maryland
• Baltimore
• Malaysia
• Madeira
• Luxembourg
• Baton Rouge
• Lichtenstein
• Liberia
• Labuan
• Kuwait
• Seoul
• Louisville
• Jersey, Guernsey, and Sark
• Japan
• Jamaica
• Padua
• Milan
• Rome
• Tel Aviv
• Isle of Jersey
• Ireland
• Isle of Man
• Iraq
• Iran
• Indonesia
• Highland Park
• Iceland
• Hungary
• Houston
• Holland
• Hillsborough
• Hialeah
• Hawaii
• Port-au-Prince
• Guyana
• Guam
• Grenada
• Gibraltar
• Hamburg
• Berlin
• Germany
• Atlanta
• Paris
• France
• West Palm Beach
• Tampa
• Tallahassee
• Hollywood
• Orlando
• Clearwater
• Ocala
• London
• Sheffield
• Cook Islands
• Iguique
• Cape Verde Islands
• Santa Monica
• Solana Beach
• Broward
• Brevard
• Manaus
• Belo Horizonte
• Duval
• Ciudad del Este
• Dubai
• Santo Domingo
• Dominica
• Copenhagen
• Denmark
• Cyprus
• Curacao
• Cuba
• Croatia
• Boulder
• Denver
• Colorado
• Broomfield
• Bogota
• Medellin
• San Juan
• Iguique
• Chile
• Santiago
• Chicago
• Cape Verde Islands
• Canary Islands
• Montreal
• Calgary
• Santa Monica
• Solana Beach
• New York
• Amsterdam
• Netherlands
• Nevis
• Las Vegas
• California
• Broward
• Brevard
• British Virgin Islands
• Florianopolis
• Brazil
• Pouso Allegre
• Foz do Iguaçu
• Manaus
• Rio de Janeiro
• Porto Allegre
• Belo Horizonte
• Sao Paolo
• Washington, D.C.
• Venezuela
• US Virgin Islands
• Uruguay
• United Kingdom
• Texas
• Switzerland
• St. Kitts and Nevis
• Spain
• Scotland
• Sarasota
• San Francisco
• Russia
• Puerto Rico
• Pinellas
• Peru
• Paraguay
• Panama
• Palm Beach
• New Jersey
• Miami, Florida
• Mexico
• Malta
• Madison
• Los Angeles
• Jefferson
• Italy
• Israel
• India
• Hong Kong
• Honduras
• Haiti
• Guatemala
• Greece
• Florida
• Dominican Republic
• Costa Rica
• Colombia
• Cayman Islands
• China
• Canada
• Boca Raton
• Bermuda
• Berlin
• Belize
• Belgium
• Barbados
• Bahamas, Freeport
• Bahamas
• Austria
• Australia
• Aruba
• Arkansas
• Arizona
• Argentina
• Antigua
• Andorra
• American Samoa
• Albuquerque
• Alabama
• Argentina, Buenos Aires

Carousels

• Community Organizations
• Professional Organizations